Diagnosing and treating patients well starts with choosing the most precise test. Cardiac PET imaging is the test of choice more often these days when it comes to assessing coronary artery disease, myocardial perfusion, viability and ventricular function in more complex patients. It makes sense clinically, operationally and financially. It also trumps SPECT in many ways, and can even play a role in cardiac disease prevention.
Learn from this panel of experts about which patients benefit most and the advantages cardiac PET brings in:
- Myocardial blood flow assessment in detecting coronary artery disease
- Assessing viable myocardium in dysfunctional left ventricular regions, examining transplants and vasculopathy
- Detecting cardiac sarcoidosis and infections in implanted cardiac devices
- Even avoiding unnecessary interventional procedures
For physicians and administrators alike, cardiac PET can add value to clinical practice and patient and practice management.
|Vasken Dilsizian, MD
Professor of Medicine and Radiology University of Maryland School of Medicine
|Timothy Bateman, MD
Co-Director, Cardiovascular Radiology Mid America Heart Institute Professor of Medicine University of Missouri at Kansas City
Randall Thompson, MD
|Patrick Bering, MD
Chief Cardiology Fellow University of Maryland Medical Center
19 more things you need to know about cardiac PET!
(hint: we answered ALL the webinar audience questions)
It was a good problem to have. We had way too questions proposed during the webinar expert Q&A than we could answer. So we reconvened the expert panel with Drs. Dilsizian, Bateman, Thompson and Bering to answer them ALL! Check out the bonus answers—on reimbursement, patient selection, building physician awareness, timing for new agents on the horizon, the challenge of PET/MR and cardiac PET’s role in retasking the cath lab and even cardiac PET serving as gatekeeper. Take a look!